日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Semaglutide and Hospitalizations in Patients With Obesity and Established Cardiovascular Disease: An Exploratory Analysis of the SELECT Randomized Clinical Trial

索玛鲁肽与肥胖合并心血管疾病患者的住院情况：SELECT随机临床试验的探索性分析

期刊:Jama Cardiology
影响因子:14.1
doi:10.1001/jamacardio.2025.4824
Nicholls, Stephen J; Ryan, Donna H; Deanfield, John; Ferreira, Daniel; Lang, Chim C; Lincoff, A Michael; Lingvay, Ildiko; Lübker, Christopher; Terns, Paula Pérez; Rasmussen, Søren; Stensen, Signe; Weeke, Peter E; Kahn, Steven E
心血管疾病
SELE
心血管
代谢
肥胖
发表日期：2026
文献求助 收藏

Projected life-year gains with semaglutide in individuals with cardiovascular disease without type 2 diabetes in the UK

英国接受司美格鲁肽治疗的非2型糖尿病心血管疾病患者的预期寿命延长

期刊:Endocrine Connections
影响因子:2.8
doi:10.1530/EC-25-0903
Van Sloten, Thomas; Hageman, Steven H J; Westerink, Jan; Capucci, Silvia; Diogo da Rocha Fernandes, João; Holloway, Sara; Pijper, Andrew; Tikhonovsky, Natalie; Emerson, Scott; Lincoff, A Michael; Plutzky, Jorge; Lingvay, Ildiko
糖尿病
心血管疾病
心血管
代谢
发表日期：2026
文献求助 收藏

Clinical Use of Once-Weekly Insulin Icodec: Translating Clinical Trial Data into Practical Guidance for Diabetes Management

每周一次胰岛素艾可迪克（Icodec）的临床应用：将临床试验数据转化为糖尿病管理的实用指南

期刊:Drugs
影响因子:14.4
doi:10.1007/s40265-025-02201-0
Philis-Tsimikas, Athena; Aberle, Jens; Bajaj, Harpreet; Lingvay, Ildiko; Mu, Yiming; Shaikh, Shehla; Vianna, André; Watada, Hirotaka; Del Prato, Stefano
代谢
糖尿病
免疫/内分泌
发表日期：2025
文献求助 收藏

Once-weekly IcoSema versus once-weekly semaglutide in adults with type 2 diabetes: the COMBINE 2 randomised clinical trial

每周一次 IcoSema 与每周一次 semaglutide 治疗 2 型糖尿病成人患者的疗效比较：COMBINE 2 随机临床试验

期刊:Diabetologia
影响因子:10.2
doi:10.1007/s00125-024-06348-5
Lingvay, Ildiko; Benamar, Malik; Chen, Liming; Fu, Ariel; Jódar, Esteban; Nishida, Tomoyuki; Riveline, Jean-Pierre; Yabe, Daisuke; Zueger, Thomas; Réa, Rosângela
糖尿病
代谢
发表日期：2025
文献求助 收藏

Correction: Once-weekly IcoSema versus once-weekly semaglutide in adults with type 2 diabetes: the COMBINE 2 randomised clinical trial

更正：每周一次 IcoSema 与每周一次 semaglutide 在 2 型糖尿病成人患者中的比较：COMBINE 2 随机临床试验

期刊:Diabetologia
影响因子:10.2
doi:10.1007/s00125-025-06435-1
Lingvay, Ildiko; Benamar, Malik; Chen, Liming; Fu, Ariel; Jódar, Esteban; Nishida, Tomoyuki; Riveline, Jean-Pierre; Yabe, Daisuke; Zueger, Thomas; Réa, Rosângela
糖尿病
代谢
发表日期：2025
文献求助 收藏

Response to Electronic Health Record Patient Portal-Based Clinical Study Invitations

对基于电子健康记录患者门户的临床研究邀请的回应

期刊:Jama Network Open
影响因子:9.7
doi:10.1001/jamanetworkopen.2025.31624
Navar, Ann Marie; Esselink, Kathleen; Lingvay, Ildiko; Varghese, Mereeja; Li, Hong; Brunson, F Aaron; Turer, Robert W; Peterson, Eric D
发表日期：2025
文献求助 收藏

Albuminuria and Rapid Kidney Function Decline as Selection Criteria for Kidney Clinical Trials in Type 1 Diabetes Mellitus

蛋白尿和肾功能快速下降是1型糖尿病肾脏临床试验的选择标准

期刊:Clinical Journal of the American Society of Nephrology
影响因子:7.1
doi:10.2215/CJN.0000000000000567
Keum, Youngshin; Caramori, Maria Luiza; Cherney, David Z; Crandall, Jill P; de Boer, Ian H; Lingvay, Ildiko; McGill, Janet B; Polsky, Sarit; Pop-Busui, Rodica; Rossing, Peter; Sigal, Ronald J; Mauer, Michael; Doria, Alessandro
糖尿病
代谢
发表日期：2025
文献求助 收藏

Characteristics of patients prescribed SGLT-2i and/or GLP-1RA among cardiology clinics in the US: insights from the COORDINATE-diabetes trial

美国心脏病诊所中接受SGLT-2抑制剂和/或GLP-1受体激动剂治疗的患者特征：来自COORDINATE-diabetes试验的启示

期刊:American Journal of Preventive Cardiology
影响因子:5.9
doi:10.1016/j.ajpc.2025.101058
Nelson, Adam J; Kaltenbach, Lisa A; Al-Khalidi, Hussein R; Leyva, Monica; Webb, Laura; McGuire, Darren K; Pop-Busui, Rodica; Cavender, Matthew A; Aroda, Vanita R; Magwire, Melissa L; Richardson, Caroline R; Lingvay, Ildiko; Kirk, Julienne K; Pandey, Ambarish; Gaynor, Tanya; Pak, Jonathan; Washington, Alana; Senyucel, Cagri; Lopes, Renato D; Green, Jennifer B; Granger, Christopher B; Pagidipati, Neha J
心脏病
信号转导
心血管
GLP-1
发表日期：2025
文献求助 收藏

Weight reduction over time in tirzepatide-treated participants by early weight loss response: Post hoc analysis in SURMOUNT-1

接受替拉帕肽治疗的受试者在早期体重减轻反应方面随时间推移的体重减轻情况：SURMOUNT-1 研究的事后分析

期刊:Diabetes Obesity & Metabolism
影响因子:5.7
doi:10.1111/dom.16554
Ard, Jamy; Lee, Clare J; Gudzune, Kimberly; Addison, Brandi; Lingvay, Ildiko; Cao, Dachuang; Mast, Casey J; Stefanski, Adam; Falcon, Beverly; Mojdami, Donna
发表日期：2025
文献求助 收藏

Adherence to app-based dose guidance for once-weekly insulin icodec in insulin-naive individuals with type 2 diabetes: Post hoc analysis of ONWARDS 5

在未接受过胰岛素治疗的 2 型糖尿病患者中，每周一次使用胰岛素 icodec 时，基于应用程序的剂量指导的依从性：ONWARDS 5 的事后分析

期刊:Diabetes Obesity & Metabolism
影响因子:5.7
doi:10.1111/dom.16597
Bajaj, Harpreet S; Bennedsen, Lars Villads; Donatsky, Anders Meller; Martiny, Johannes Handberg Juul; Vianna, André; Lingvay, Ildiko
代谢
糖尿病
免疫/内分泌
发表日期：2025
文献求助 收藏